Evaluation of the clinical outcomes of Benidipine initiated by physician's preference in patients with hypertension and/or angina pectoris (chronic coronary syndrome) presenting to cardiology outpatient clinics in Turkey.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with hypertension and/or angina pectoris on the background of chronic coronary syndrome who have been receiving Benidipine treatment for at least 1 month and will continue to receive Benidipine treatment
* Male or female outpatients, 18-80 years of age
* Patients with mild to moderate essential hypertension who have been receiving or will continue Benidipine treatment for at least 1 month
* Outpatients with clinically stable angina pectoris and patients who have been receiving or will continue Benidipine treatment for at least 1 month
* Those who signed the written informed consent form
Exclusion Criteria:
* Patients with secondary hypertension
* Emergency hypertensive patients
* Having to take other medications during the study that may affect blood pressure
* Allergic to DHP calcium antagonists
* Evidence of decompensated congestive heart failure, unstable angina or severe arrhythmia
* Severe renal or hepatic dysfunction
* Pregnant or lactating women
* Participation in other clinical trials within 3 months prior to this study
* Patients who did not sign the consent form of the study
What they're measuring
1
The Percentage of Patients Achieving Target Sitting Blood Pressure of Less Than 130/85
Timeframe: 3 months
2
Change in angina symptom severity as measured by the Seattle Angina Questionnaire score from baseline to the end of study
Timeframe: 3 months
Trial details
NCT IDNCT06808321
SponsorThe Society of Prevention and Awareness of Cardiovascular Diseases